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A tetrameric protein of therapeutic importance, Escherichia coli L-asparaginase-II was
expressed in Escherichia coli as inclusion bodies (IBs). Asparaginase IBs were solubilized
using low concentration of urea and refolded into active tetrameric protein using pulsatile
dilution method. Refolded asparaginase was purified in two steps by ion-exchange and
gel filtration chromatographic techniques. The recovery of bioactive asparaginase from
IBs was around 50%. The melting temperature (Tm) of the purified asparaginase was
found to be 64◦C. The specific activity of refolded, purified asparaginase was found to
be comparable to the commercial asparaginase (190 IU/mg). Enzymatic activity of the
refolded asparaginase was high even at four molar urea solutions, where the IB aggregates
are completely solubilized. From the comparison of chemical denaturation data and activity
at different concentrations of guanidine hydrochloride, it was observed that dissociation of
monomeric units precedes the complete loss of helical secondary structures. Protection
of the existing native-like protein structure during solubilization of IB aggregates with 4M
urea improved the propensity of monomer units to form oligomeric structure. Our mild
solubilization technique retaining native-like structures, improved recovery of asparaginase
in bioactive tetrameric form.
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INTRODUCTION
Most of the times, expression of recombinant proteins in
Escherichia coli leads to the formation of insoluble aggregates
known as IBs (Hartley and Kane, 1988; Fahnert et al., 2004).
Recovery of active protein from IB aggregates remains to be
a cumbersome task and requires standardization of solubiliza-
tion and refolding methods (De Bernardez et al., 1999; Burgess,
2009). The major hurdle associated with purification of proteins
from IBs is the sub-optimal refolding of recombinant proteins
into native conformation (Rudolph and Lilie, 1996; Panda, 2003;
Vallejo and Rinas, 2004). Poor refolding is often associated to high
concentrations of urea or guanidine hydrochloride (GdmCl) used
to solubilize the IB proteins. At higher concentrations, chaotropes
such as urea and GdmCl completely denature the proteins and
increases its propensity to aggregate during refolding resulting
in low recovery of bioactive protein from IBs. IB proteins are
reported to have structure and functional activities (Umetsu et al.,
2004; Ventura and Villaverde, 2006; Peternel and Komel, 2011).
These active IBs can be isolated from bacterial cells using differ-
ent methods like homogenization, enzymatic lysis, and sonication
where homogenization was observed to be most appropriate
(Peternel and Komel, 2010). It will be ideal to protect these sec-
ondary protein structures during IB solubilization process. Mild
solubilization of IB aggregates protects the existing native-like
protein structure of IB proteins and helps in its improved recovery
into bioactive form Singh and Panda (2005). In a few cases, solu-
bilization with mild denaturing conditions has been proved to be
more efficient for the recovery of bioactive protein from the IBs
(Panda, 2003; Singh et al., 2012; Upadhyay et al., 2012).
Refolding yield of active oligomeric proteins from IBs is even
lower (Scrofani et al., 2000; Karumuri et al., 2007; Garrido
et al., 2011). Formation of active monomer and its associa-
tion is a prerequisite for refolding into fully active oligomeric
proteins. Often it is hindered due to complete unfolding of
proteins in IBs into random coil structure while using high
concentration of chaotropes. Solubilized protein molecules have
propensity to form intermolecular aggregates leading to mas-
sive aggregation during refolding. It is thus essential to pro-
tect the secondary helical structure of IB proteins so that it
reduces intermolecular aggregation between monomers. It can
be achieved by adopting mild solubilization process for solubi-
lization of IBs. Chemical denaturation studies provide informa-
tion about the solubility profile of IB aggregates. Based on this
information, IBs can be solubilized at low denaturation con-
centration while protecting the existing native-like secondary
protein structure. Refolding of protein from monomers having
secondary structural element will promote monomer associa-
tion leading to the formation of active oligomeric protein and
thus will improve the overall recovery of bioactive protein from
IBs. Even though mild solubilization processes have been used to
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recover bioactive protein from IBs, there is very little information
available on the refolding of oligomeric proteins into bioactive
form.
Bacterial asparaginases from Escherichia coli and Erwinia
chrysanthemi have been extensively used as drugs for the treat-
ment of acute lymphoblastic leukemia (Muller and Boos, 1998;
Graham, 2003; Verma et al., 2007). L-asparaginases (EC 3.5.1.1)
catalyze the hydrolysis of L-asparagine to L-aspartic acid and
ammonia. All asparaginases consist of four identical subunits
A, B, C, and D and exist in homo-tetrameric form (Kozak
et al., 2002) having masses in the range of 140–150 kDa (Aung
et al., 2000). One subunit consists of two α/β domains that are
connected by linking sequence. Interaction between N and C-
terminal domain of adjacent monomers forms each active site.
Therefore, the asparaginase tetramer can be treated as dimer of
dimers because active site is either created by subunits A and
C or B and D. The active form of the enzyme is a tetramer,
and the dimers lack enzyme activity (Swain et al., 1993). L-
asparaginase contains one tryptophan molecule at 66 positions in
each monomer. It consists of four active sites formed at the inter-
faces of N and C- terminal domains of two interacting monomers
(Swain et al., 1993). L-asparaginase has been reported to be pro-
duced using recombinant E. coli (Khushoo et al., 2004; Oza et al.,
2011), P. pastoris (Ferrara et al., 2010) and from other microor-
ganisms (Mahajan et al., 2012). Most of the times, the enzymes
is produced in soluble form and purified with 40–60% recovery.
There are no reports till date on solubilization and refolding of
L-asparaginase from IBs into bioactive tetrameric form.
In this work, E. coli L-asparaginase II was expressed in E. coli
cells as IBs and used as a model system to refold into bioac-
tive tetrameric form. Attempts were made to solubilize the IBs of
asparaginase in mild denaturing conditions. Solubilized proteins
were then refolded and purified into active oligomeric form. Role
of structural integrity between monomers and their importance
in regulation of enzyme activity and stability was monitored by
chemical, pH, temperature and organic solvent based denatura-
tion methods. The results are of indication that mild solubiliza-
tion followed by pulsatile refolding leads to improved recovery of
bioactive multimeric L-asparaginase from IBs of E. coli.
MATERIALS AND METHODS
CHEMICALS
Culture media ingredients, tryptone, and yeast extract were from
Difco Laboratories, India. Tris buffer, glycine, IPTG, sodium
dodecyl sulfate, PMSF, and deoxycholic acid were from Amresco,
USA. Ammonium persulfate, acrylamide, bis-acrylamide, E. coli
asparaginase, L-arginine and Urea were from Sigma Chemicals,
USA. DEAE-sepaharose and S-200 gel filtration matrix was from
GEHealthcare, Sweden. TEMED, EDTA, bromophenol blue from
Biorad, USA. Coomassie brilliant blue R-250 and ampicillin
fromUSBCorporation, Cleveland, Ohio. Glucose, NaCl, Nessler’s
reagent, and other chemicals were from Qualigen, India.
ESCHERICHIA COLI STRAINS AND CLONING OF L-ASPARAGINASE
Escherichia coli BL21 (DE3) strain was from Novagen,
USA. E. coli DH5α strain was obtained from Amersham
Bioscience, USA. Plasmid pET14b was from Novagen, USA.
L-asparaginase II (ansB) gene was amplified from the genomic
DNA of E. coli K-12 strain (JM109) using primers (forward)
5′GTGCAGCACATATGTTACCCAATA TCACCA 3′and (reverse)
5′ GGCGGGATCCTTAGTACTGATTGAAGA 3′. NdeI and
BamHI restriction sites were incorporated in the primers to
facilitate cloning of the structural asparaginase gene (without
its native signal sequence) in the E. coli expression vector
pET14b. E. coli BL21 (DE3) cells were transformed with recom-
binant pET14b plasmid vector and used for expression of
L-asparaginase II.
EXPRESSION AND ISOLATION OF ASPARAGINASE IBs
Transformed E. coli BL21 (DE3) cells were grown in modified LB
media (1% tryptone, 0.5% yeast extract, 0.5% glucose and 1%
NaCl) with 100μg/ml ampicillin at 37◦C in incubator shaker at
200 rpm. Culture at an OD600 of 0.6 was induced with 1mM
IPTG and was further grown for 3.5 h. Cells (1 L culture) were
pelleted at 6000 rpm (rotor SLA-3000, Sorvall evolution RC) for
10min at 4◦C. Supernatant was discarded and culture pellet was
resuspended in 20ml buffer I (50mM Tris-HCl, 1mM EDTA,
1mM PMSF, pH 8.5) containing egg white lysozyme (1mg/ml)
and incubated at room temperature for 2 h. Re-suspended cells
were sonicated for 10 cycle (1min cycle with 1min gap) using
Branson sonifier 450, Germany (probe diameter 13mm, output
voltage 60 and 50% duty cycle). Sonicated cells were centrifuged
at 12,000 rpm (SA-300 rotor, Sorvall evolution RC) for 20min at
4◦C and the pellet containing recombinant asparaginase as IBs
was separated. These pellets were resuspended in 20ml buffer
I containing 0.1% (w/v) deoxycholic acid, sonicated and cen-
trifuged as described earlier (Patra et al., 2000). Pellet was fur-
ther washed two times with buffer I and once with de-ionized
water. Washed pellet (purified IBs) was resuspended in 1ml
50mM Tris-HCl buffer, pH 8.5 and used for solubilization and
refolding.
SOLUBILIZATION AND REFOLDING OF ASPARAGINASE FROM IBs
Isolated asparaginase IBs (1ml) were solubilized in 9ml
buffer II (4M urea, 50mM Tris-HCl, 1mM PMSF, 20mM
β-mercaptoethanol, 10mM NaCl, pH 8.5) and kept for one
h at room temperature. Solubilized asparaginase was cen-
trifuged at 15,000 rpm for 30min and supernatant was filtered
through 0.2μm filter (Millipore, USA). Solubilized protein was
refolded into 90ml buffer III (0.5M urea, 50mM Tris-HCl,
0.1M arginine, 10mM NaCl) by pulsatile dilution method at
flow rate of 0.1ml/min at 4◦C. Refolded sample was cen-
trifuged at 15,000 rpm (rotor SA-300, Sorvall evolution RC)
for 30min at 4◦C. Supernatant was collected and dialyzed
against buffer (50mM Tris-HCl, 0.5M urea, pH 8.5) using dial-
ysis tubing (10 kDa, molecular weight cut-off) for 4 h at 4◦C.
Buffer was exchanged three times with 50mM Tris-HCl, pH
8.5, at 4 h interval. Dialyzed protein was pooled and used for
purification.
PURIFICATION OF REFOLDED RECOMBINANT L-ASPARAGINASE
Refolded L-asparaginase was purified using DEAE-sepharose
anion exchange matrix packed in XK 16 column (GE Healthcare,
Sweden). Refolded asparaginase was loaded on to the column
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at flow rate of 1ml/min and column was washed with 3 bed
volumes of 50mM Tris-HCl buffer at pH 8.5. Recombinant
asparaginase was eluted from column using 0 to 0.5M con-
tinuous gradient of NaCl. Fractions (2ml each) were collected
and analyzed by 12% SDS polyacrylamide gel electrophore-
sis. Ion exchange fractions containing asparaginase were pooled
and concentrated by ultra-filtration (10 kDa molecular weight
cut-off) to the final volume 5ml. Concentrated asparagi-
nase was loaded on S-200 Sephacryl column (XK16/60, GE
Healthcare, Sweden) pre-equilibrated with 50mM Tris-HCl,
10mM NaCl, pH 7.5 buffer at flow rate 0.5ml/min. Eluted
tetramer fractions were pooled, concentrated and used for
activity assay and characterization. All chromatography exper-
iments were carried out using AKTA protein purifier (GE
Healthcare, Sweden). SDS polyacrylamide gel electrophoresis
was performed according to method of Laemmli on a slab gel
containing 12% running gel and 5% stacking gel (Laemmli,
1970).
PROTEIN ESTIMATION AND MASS SPECTROMETRY
Protein concentration was determined by micro BCA assay kit
(Pierce, Germany) using BSA as a standard. For enzyme assay
and spectral analysis purified protein concentration was calcu-
lated by spectroscopic method using λ280 nm (1mg/ml = 0.77
for purified asparaginase). Purified recombinant asparaginase
was passed through desalting column to remove salts and other
small molecules. Recombinant asparaginase (10μg/ml) dissolved
in 1% formic acid was used for mass spectroscopy analysis. Mass
spectrum was collected using LC MS MS system (Waters, USA).
ANALYTICAL GEL FILTRATION CHROMATOGRAPHY USING HPLC
SYSTEM
Purified recombinant asparaginase was loaded on protein Bio-
Sep S-2000 column (Phenomenex, Torrence, USA) attached to
HPLC system (Shimadzu, Japan) to analyze oligomeric form of
the recombinant protein. For this, a Bio-Sep S-2000 column was
equilibrated with 50mM Tris-HCl, 10mM NaCl, pH 7.5 and
20μl of 1.5mg/ml purified recombinant asparaginase solution
was injected in the column. Equilibration and elution was carried
out at a flow rate of 1ml/min. Gel filtration marker proteins (GE
Healthcare, Sweden) were applied on the column for estimation
of molecular mass of recombinant L-asparaginase.
ASPARAGINASE ACTIVITY ASSAY
Asparaginase activity was assayed using method described by
Wriston (1985). Briefly, reaction mixture consisted of 50mM
Tris-HCl (pH 8.6) and 8.6mM L-asparagine incubated at 37◦C
for 10min. L-asparaginase enzyme solution (10μg/ml) was
added in reaction mixture and incubated at 37◦C. Reaction was
stopped by adding 1.5M trichloro acetic acid at different time
points and samples were centrifuged and used for estimation of
released ammonia by Nessler’s reagent using ammonium sulfate
as standard. Time dependent release of ammonia was deter-
mined by taking ODmeasurements at 432 nm and linear range of
ammonia release was found to be up to 30min. An international
unit (IU) of L-asparaginase is defined as the amount of enzyme
required to release one micromole of ammonia per min under
the condition of the assay at saturating substrate concentration.
Assays were run in triplicate.
FLUORESCENCE AND FAR-UV CD SPECTROSCOPY OF PURIFIED
ASPARAGINASE
Fluorescence emission spectra of purified recombinant asparag-
inase were recorded using the Cary Eclipse spectrophotometer
(Varian, Australia) attached with Peltier temperature controller.
Spectra were recorded on 1 cm path length cuvettes with excita-
tion and emission slit width 5 nm. 25μg/ml concentrations were
used for acquisition of fluorescence emission spectra. Samples
were excited at 280 nm and emission spectra were collected
from 290 to 400 nm. Far-UV CD spectra were recorded using
Jasco-spectropolarimeter equipped with a Peltier temperature
controller. Spectra were acquired with a bandwidth of 1 nm, a
step size of 1 nm, and an accumulation of 100 nm per min for
three scans. Protein concentration used for CD spectroscopy was
0.4mg/ml. Asparaginase was denatured in different concentra-
tions of GdmCl. Melting curves were recorded at 222 nm during
sample heating and consecutive cooling from 20 to 90◦C, with
5◦C increment in base region and at 1◦C in transition region of
thermal denaturation.
DETERMINATION OF CONFORMATIONAL STABILITY OF
L-ASPARAGINASE
Stability of the active asparaginase tetramer was monitored by
measurements of its tryptophan fluorescence at various concen-
trations of denaturants. Purified asparaginase was denatured in
different concentrations of urea and GdmCl. In all the denatu-
ration studies, final concentration of asparaginase in denaturing
buffer was 10μg/ml. Fluorescence emission spectra were recorded
in a Cary Eclipse spectrophotometer (Varian, Australia). Samples
were excited at 280 nm and emission spectra were recorded
between 300 and 400 nm. Analysis of denaturation process was
carried out by plotting the ratios of fluorescence intensities
(319/355 nm) as function of denaturant concentration.
RESULTS
EXPRESSION OF RECOMBINANT L-ASPARAGINASE IN E. COLI
Transformed E. coli cells were induced at optical density of 0.6 at
600 nmwith 1mM IPTG and expression of recombinant asparag-
inase was checked on 12% SDS polyacrylamide gel. Recombinant
L-asparaginase was expressed as a ∼37 kDa protein and most of
it accumulated as intracellular aggregates (Figure 1A). In shaker-
flask culture at OD600 of 1.5, around 120mg of L-asparaginase
was produced as IB aggregates. We lysed the cells by sonication
in the presence of lysozyme and IB pellet was extensively washed
with 0.1% Na deoxycholate. Use of lysozyme during cell lysis
helped in better recovery of IB aggregates from cells. Washing the
IB pellet with 0.1% deoxycholic acid helped in the removal of con-
taminatingmembrane proteins. Purified IB pellet was observed to
consist of two major bands on SDS-PAGE gel, one corresponds
to recombinant L-asparaginase (85%) and another one to the
lysozyme used during IBs isolation (Figure 1B). It was observed
that small fraction of lysozyme may stick to IBs during isolation
step. This was also observed by others in their study (Peternel and
Komel, 2010).
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FIGURE 1 | SDS-PAGE analysis of expression and purification of
recombinant L-asparaginase II from E. coli IBs. Samples were
analyzed on 12% polyacrylamide gel. Lane M; low molecular weight
marker proteins (Pharmacia, Sweden) in (A–E). Arrow indicates
recombinant asparaginase. (A) Lane 1: uninduced cell lysate; lane 2:
induced cell lysate. (B) Lane 1: purified IBs. (C) Lane 1–9: supernatants
of solubilized asparaginase from IBs in 0 to 8 molar urea respectively
in 50mM Tris pH 8.5 buffer. (D) Eluted fractions of asparaginase from
DEAE ion exchange chromatography. Lanes 1–9 are eluted fractions 1,
3, 5, 7, 9, 11, 13, 15, and 17 from DEAE ion exchange chromatography.
(E) Lane 1: purified recombinant asparaginase after S-200 gel
chromatography.
REFOLDING AND PURIFICATION OF ASPARAGINASE FROM IBs
Isolated and purified L-asparaginase IBs were solubilized in dif-
ferent concentrations of urea in 50mMTris-HCl buffer at pH 8.5.
4M urea completely solubilized the recombinant L-asparaginase
IBs (Figure 1C). An extra major protein band was observed
above the recombinant L-asparaginase band in Figure 1C. This
protein band probably represents the host chaperone protein
(DnaJ ∼40 kDa) expressed during recombinant expression of L-
asparaginase. The solubility of asparaginase IBs in 4M urea con-
taining Tris-HCl was found to be ∼10mg/ml. Solubilized recom-
binant asparaginase was refolded by pulsatile dilution method.
Presence of 0.1M arginine in refolding buffer reduced protein
aggregation, promoted tetramer formation and improved the
protein recovery during refolding. Refolded asparaginase was
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Table 1 | Purification of recombinant E. coli L-asparaginase II from IBs (culture volume 1 liter).
Fractions Total protein (mg) Specific activity (IU/mg)a Fold purificationb % Yield
Total cell protein 580 – – –
IBs 118 – – 100
Solubilized protein 110 – – 93.2
Refolded protein 97 125 1 82.2
DEAE ion-exchange chromatography 78 160 1.3 66.1
Gel filtration chromatography 60 190 1.5 50.8
aOne international unit is defined as amount of enzyme required to produce one micromole of ammonia per min under standard condition of reaction.
bFold purification was calculated after refolding as the ratio of specific activity at given step of purification to specific activity of refolded sample.
FIGURE 2 | Characterization of purified asparaginase. (A) Mass
spectrogram of purified asparaginase. Protein was dissolved in 0.1%
formic acid and spectrum was obtained from LCMS instrument,
Waters, USA. (B) HPLC size exclusion chromatogram of purified
recombinant asparaginase loaded on Bio-Sep S-2000 column
(Phenomenex, USA). Elution profile shows the presence of single
peak corresponding to the asparaginase tetramer of ∼150 kDa and
retention time 6.08min.
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dialyzed and loaded on DEAE ion-exchange chromatographic
column. Refolded asparaginase was eluted at a conductance of
8–20mS/cm. Eluates from ion exchange chromatography were
analyzed by SDS-PAGE and found to be 95% pure (Figure 1D).
Ion exchange fractions containing asparaginase were pooled and
concentrated by ultra-filtration (10 kDa molecular weight cut-
off) unit and loaded on S-200 column to separate the monomer
and other higher soluble aggregates species from tetramer. The
eluted asparaginase was pure (Figure 1E). Maximum step recov-
ery of protein was achieved during solubilization and refold-
ing steps (Table 1). Approximately 60mg of purely refolded
L-asparaginase was recovered from 1 L shaker -flask culture.
The overall recovery of the bioactive enzyme from the IBs
was ∼50%. Mass spectroscopy data analysis showed the molec-
ular weight of purified asparaginase single subunit to be equal
to ∼36.7 kDa that is equal to calculated molecular weight of
recombinant asparaginase with six histidine tags (Figure 2A).
To check whether purified recombinant asparaginase consists
of a mixture of large molecular aggregates and monomer form
other than the native tetramer, purified protein was loaded on
BioSep S-2000 column. Purified recombinant asparaginase was
eluted at retention time 6.08min at 1ml/min flow rate with
100% peak intensity (Figure 2B). Molecular weight of eluted
asparaginase was calculated using standard calibration curve plot-
ted using different marker proteins and found to be close to
150 kDa. Molecular weight of purified asparaginase was found
to be 8–10 kDa more due to the addition ∼2 kDa N-terminal
His-tag in each subunit of active tetramer. This result showed
that the purified recombinant asparaginase was in tetrameric
form.
ENZYME ACTIVITY AND DETERMINATION OF KINETIC PARAMETERS
OF PURIFIED ASPARAGINASE
Steady-state kinetic analysis of recombinant L-asparaginase was
carried out at saturating substrate concentration of L-asparagine
to determine its specific activity. Time duration of the reaction
was determined by calculating linear range of ammonia release
from both recombinant and native asparaginase (Figure 3A). It
was observed that up to 30min, the amount of ammonia release
was linear (R2 value for native protein on linear fit was 0.991 and
for recombinant asparaginase it was 0.990). As the protein was
refolded and purified, the specific activity increased from 125 to
FIGURE 3 | Bioactivity of purified asparaginase. (A) Time dependent
ammonia release per ml of reaction mixture (Y axis) for native (--)
and recombinant (--) asparaginase was calculated by Nessler’s
reagent method. Amount of asparaginase enzyme in final reaction
buffer was 10μg/ml. (B) Effect of L-asparagine concentration on
specific activity of recombinant asparaginase. (C) Double reciprocal
plot between velocity and L-asparagine concentration for determination
of Km and Vmax values. (D) Fluorescence emission spectra of the
native (—) and purified recombinant (− − −−) L-asparaginase II at
15μg/ml concentration in 50mM Tris-HCl buffer, pH 7.5. Emission
spectra show maxima at 320 nm with two shoulders at 307 and
325 nm at 280 nm excitation wavelengths.
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190 IU/mg (Table 1). Specific activity of final purified protein was
found close to native E. coli asparaginase (200 IU) and was around
190 ± 5 IU. The kinetic parameters for purified asparaginase
were calculated by determining the specific activity of asparag-
inase at different concentrations of L-asparagine (0.1–10mM)
(Figure 3B). The Km and Vmax value were calculated from the
linear fit of double reciprocal Lineweaver-Burk plot (Figure 3C).
The Km and Vmax values for purified protein were found to be
2.58mM L-asparagine and 256 IU/mg respectively. The fluores-
cence spectrum of the refolded asparaginase was comparable to
that of the native enzyme (Figure 3D). The similarity of specific
activities and fluorescence spectrum of the refolded enzyme with
the native asparaginase indicated that the recombinant protein
has been refolded into native-like conformation.
CHEMICAL DENATURATION OF ASPARAGINASE BY UREA AND GdmCL
Chemical denaturation of asparaginase was probed by fluores-
cence spectroscopy in the presence of different concentrations of
urea and GdmCl. The protein was excited at 280 nm, and emis-
sion spectra were recorded between 300 and 400 nm. Fluorescence
spectra of asparaginase in the presence of different concentra-
tions of urea and GdmCl are presented in Figures 4A,B. Native
asparaginase showed emission maximum at 319 nm. In the pres-
ence of 6M urea or 2M GdmCl, complete denaturation of the
protein was observed with emission maximum at 356 nm that is a
characteristic feature of solvent- exposed tryptophan residues in
polar environment. Fluorescence intensity was reduced with the
increase in urea concentration (up to 4M) without any signifi-
cant shift in emission maxima. However, there was a 36 nm red
shift in emission maximum of asparaginase at higher than 4M
urea concentrations. Similar denaturation behavior was observed
in the presence of GdmCl. However, being a stronger denaturant,
loss of fluorescence intensity and red shift in emission maximum
occurred at 1.2M concentration of GdmCl. As asparaginase has
characteristic emission maxima wavelength in native and dena-
tured states, denaturation curves of asparaginase were analyzed
as ratios of fluorescence intensities at 319/356 nm at different
concentrations of urea and GdmCl. Asparaginase showed coop-
erative denaturation profile in urea and GdmCl (Figures 4C,D).
It can be concluded that asparaginase is more susceptible to
GdmCl denaturation in comparison to urea. This conclusion was
further supported by the denaturation profiles of asparaginase
in presence of GdmCl observed with circular dichroism (CD)
spectroscopy (Figure 5).
 
A
B
C
D
FIGURE 4 | Fluorescence emission spectra of L-asparaginase denatured
in different concentrations of denaturants in pH 8.5, Tris-HCl buffer.
(A) Emission spectra in presence of urea. (B) Emission spectra in presence
of GdmCl. Colored bars indicate the molar concentrations of denaturants.
ex = 280 nm. Denaturation profile of recombinant asparaginase in (C) urea
and (D) GdmCl.
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FIGURE 5 | Far-UV CD spectra of asparaginase in presence of different
concentrations of GdmCl. Colored bars show the concentrations of
GdmCl.
We determined the asparaginase enzymatic activity in the
presence of denaturants such as urea and GdmCl at different con-
centrations to gain information on the stability of quaternary
structure. The denaturant concentration-dependent activity pro-
file of asparaginase is shown in Figure 6A. No significant loss
in activity of asparaginase till 4M urea was observed. Similarly,
asparaginase retained 80% activity in 0.8M GdmCl. The GdmCl
concentration-dependence of fluorescence spectra, CD signal
at 222 nm and enzyme activity of asparaginase was compared
(Figure 6B). Fluorescence signal and activity were found to be in
agreement. However, the CD signal at 222 nm showed a biphasic
denaturation behavior in which first transition state was simi-
lar to the fluorescence and activity profile. The second transition
state was observed between 1.4 and 1.8M concentrations of
GdmCl where the protein retained some proportion of secondary
structures.
THERMAL DENATURATION AND DETERMINATION OF MELTING
TEMPERATURE
Thermal stability of purified recombinant asparaginase was
probed by CD and fluorescence spectroscopy. The CD spectra of
asparaginase were recorded at different temperatures (Figure 7A).
Samples were left for 5min for equilibration at each point, and
three scans were recorded. In pre-and post-transition range of
thermal denaturation, scans were performed at 5◦C intervals and
1◦C intervals within the transition range. CD 222 nm signals were
plotted against temperature (Figure 7B). Thermal denaturation
curves showed the loss of CD signal at start of 57◦C and gradually
decreased to the lowest value at 70◦C. Further increase in temper-
ature beyond 70◦C had no significant effect on CD 222 nm signal.
The melting temperature (Tm) of asparaginase was found to be
64◦C at pH 8.0. Similarly, the thermal denaturation of asparagi-
nase was probed by acquiring the fluorescence spectra at different
temperatures (Figure 7C). Ratio of fluorescence intensities at 319
and 355 nm (FL at 319/355 nm), was plotted against tempera-
ture (Figure 7D). The denaturation curve showed the increase in
 
A
B
FIGURE 6 | (A) Relative activity of asparaginase in presence of different
concentrations of urea and GdmCl (activity in absence of denaturants was
considered to be 100%). The colored bars indicate the denaturants.
(B) GdmCl induced denaturation curves of recombinant asparaginase. The
appropriate fraction of native protein (relative values) was plotted vs. GdmCl
concentration.
the FL at 319/355 nm) value up to 57◦C. After that, there was a
sharp decrease in this value. In post- transition range, a similar
trend was observed as in pre-transition range. The curve fitting
showed that the apparent Tm to be 65◦C. It was close to the Tm
value calculated from thermal denaturation curve plotted from
CD signals.
DISCUSSION
Refolding yield of bioactive proteins from IBs of E. coli are in
general very low and contribute toward a major cost for pro-
duction of recombinant proteins (Datar et al., 1993). However,
expression of protein as IBs has the advantages of very high level
of protein expression and resistance to protease attack. Thus,
IB expression helps in purifying the denatured protein with a
lower number of operating steps. If suitable high throughput
refolding procedure can be developed for a particular protein, IB
formation will be very helpful in the production of recombinant
protein. Such an approach will be more beneficial for oligomeric
proteins where the refolding yields are even lower. Strategy used to
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FIGURE 7 | Thermal denaturation of recombinant asparaginase.
(A) Far-UV CD spectra of asparaginase at different temperatures at
pH 8.0. (B) Thermal denaturation curve of asparaginase plotted
between CD 222nm signal and temperature. (C) Fluorescence
spectra of asparaginase at different temperatures at pH 8.0.
(D) Thermal denaturation curve of asparaginase was plotted
between FL (319/355) nm and temperature. Tm values are indicated
by arrow.
recover bioactive protein from IBs mainly involves four steps: iso-
lation of IBs from E. coli cells; solubilization of the IB aggregates;
refolding and purification of the solubilized protein. Among these
steps, solubilization of the protein aggregates and refolding of
the solubilized protein are the most crucial steps and need care-
ful attention for high recovery of protein. Aggregation leading
to low recovery of the recombinant protein occurs due to the
use of sub-optimal refolding procedure. It is expected that mild
solubilization of the IB aggregates using low concentration of
denaturants followed by pulsatile refolding of the solubilized pro-
tein would be an ideal approach for maximal recovery of bioactive
proteins from the IBs.
In this study, E. coli L-asparaginase II was expressed as IB
aggregates in E. coli, purified by detergent washing and solubi-
lized using only 4molar urea solution. Maximum of 10–11mg/ml
of the protein could be solubilized at 4M urea solution. The solu-
bilized protein was subsequently refolded into native tetrameric
form using pulsatile dilution method. Around 50% of IB pro-
tein could be refolded into bioactive tetrameric protein using the
mild solubilization procedure. The production data are compa-
rable to that reported for soluble expression using LB medium
in shaker-flask culture (Khushoo et al., 2004). It is expected that
if such expression system are optimized using high cell density
fermentation followed by the present IB refolding process, the
volumetric productivities will be even better. Crystal structure of
E. coli asparaginase shows that the active site is present between
subunits of intimate dimer formed by interaction of N-terminal
domain of one subunit with C-terminal domain of the other sub-
unit. Each dimer has two active sites, but only tetramer shows the
activity. Apart from this, 0.1M arginine in refolding buffer also
promoted the formation of tetramer and reduced the extent of
protein aggregation. It showed that the arginine not only helped
in preventing aggregation during refolding but also promoted
the formation of correctly folded subunits for proper associa-
tion into tetrameric form. Fluorescence spectrum of the refolded
asparaginase was similar to that of native asparaginase indicating
the formation of proper quaternary structure of the recombinant
asparaginase after refolding.
According to the crystal structure of asparaginase, α-helices are
predominantly present on the surface of tetramer. Active site of
asparaginase is present on the interface of subunits with trypto-
phan residues at the core of N-terminal domains of monomers
near the active site. The cooperative fluorescence and activity
profile and biphasic nature of CD spectra in the presence of dif-
ferent concentrations of GdmCl could be possible if, during the
denaturation, dissociation of subunits precedes the complete loss
of secondary structures into monomers. Protecting the existing
secondary structure element of the protein during solubilization
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thus favors the association monomer into oligomeric form and
results in the formation of tetrameric bioactive protein.
CONCLUSIONS
Understanding the solubilization profile of IB aggregates at dif-
ferent denaturation concentration helped in designing a mild sol-
ubilization procedure. Such a mild process protected the existing
native-like protein structure and thus helped in improved recov-
ery of bioactive protein during refolding. Solubilized asparag-
inase from the IBs was refolded into tetrameric form having
high specific enzymatic activity by optimization of solubiliza-
tion and refolding conditions. Purified asparaginase was found
to be active. Kinetic parameters of the enzyme were determined.
Purified asparaginase was characterized for its denaturation pro-
files in the presence of urea and GdmCl. Thermal denaturation of
the purified asparaginase was also studied, and the Tm was deter-
mined to be about 64◦C. Mild solubilization of IB protein is thus
the key requirements in high throughput recovery of IB proteins
into bioactive form. This concept thus can be used for recovery of
bioactive oligomeric proteins from the IBs of E. coli.
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